NAMIDA
Live / Registered — Registered (as of 28 Jan 2025)
What this means for you
Registered since 28 Jan 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97819600
- Registration number
- 7673580
- Mark type
- Stylized text
- Filed
- 02 Mar 2023
- Registered
- 28 Jan 2025
- Attorney of record
- Ryan D. Artis
Goods and services
- Class 005 — Pharmaceuticals: Diagnostic test kits consisting primarily of medical diagnostic immunoassays and complement diagnostic reagents for testing of human diseases, namely, breast cancer, for clinical medical testing and medical use
- Class 042 — Scientific and technological services: Biotechnology research and development; Medical research and development; Scientific research and development; Medical and scientific research services in the field of diagnostic tests for cancer, inflammatory diseases, and psychological maladies; Medical laboratories
- Class 044 — Medical, beauty and agricultural services: Providing medical screening services for cancer and inflammatory diseases, and psychological maladies; Medical screening; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical screening using protein biomarkers; Medical screening using RNA and DNA biomarkers; Medical screening service in the field of tear testing for breast health screening
Owner
- Namida Lab, Inc., Fayetteville, AR, US
- Namida Lab, Inc., Fayetteville, AR, US
Prosecution history
- 28 Jan 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 Jan 2025 — REGISTERED-SUPPLEMENTAL REGISTER
- 06 Jan 2025 — APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
- 31 Dec 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 31 Dec 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 31 Dec 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 01 Oct 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 01 Oct 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 01 Jul 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 01 Jul 2024 — NON-FINAL ACTION E-MAILED
- 01 Jul 2024 — NON-FINAL ACTION WRITTEN
- 01 Jul 2024 — USE AMENDMENT ACCEPTED
- 12 Apr 2024 — AMENDMENT TO USE PROCESSING COMPLETE
- 12 Apr 2024 — USE AMENDMENT FILED
- 12 Apr 2024 — TEAS AMENDMENT OF USE RECEIVED